Shopping Cart
- Remove All
- Your shopping cart is currently empty
JTE-952 is a oral, potent active and selective Type II inhibitor of colony stimulating factor-1 receptor (CSF-1R or cFMS, type III receptor tyrosine kinase), with IC50 values of 13 nM and 261 nM for CSF1R and TrkA , respectively. Effective against a mouse collagen-induced model of arthritis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.596 € | 8-10 weeks | |
50 mg | 2.080 € | 8-10 weeks | |
100 mg | 2.945 € | 8-10 weeks |
Description | JTE-952 is a oral, potent active and selective Type II inhibitor of colony stimulating factor-1 receptor (CSF-1R or cFMS, type III receptor tyrosine kinase), with IC50 values of 13 nM and 261 nM for CSF1R and TrkA , respectively. Effective against a mouse |
Targets&IC50 | TrkA:261 nM , CSF1R:13 nM |
In vivo | JTE-952 treatment reduces the overall progression of the clinical score, including inflammation and bone erosion in mouse model of collagen-induced arthritis (CIA model). |
Molecular Weight | 518.6 |
Formula | C30H34N2O6 |
Cas No. | 1255303-54-8 |
Relative Density. | 1.294 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.